nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C8—Salmeterol—asthma	0.0611	0.087	CbGbCtD
Nilutamide—CYP2C8—Mometasone—asthma	0.0611	0.087	CbGbCtD
Nilutamide—CYP2C8—Zafirlukast—asthma	0.0479	0.0683	CbGbCtD
Nilutamide—CYP2C19—Zafirlukast—asthma	0.0402	0.0573	CbGbCtD
Nilutamide—CYP2C19—Formoterol—asthma	0.0388	0.0553	CbGbCtD
Nilutamide—CYP2C19—Arformoterol—asthma	0.0388	0.0553	CbGbCtD
Nilutamide—CYP2C9—Zileuton—asthma	0.038	0.0541	CbGbCtD
Nilutamide—CYP2C8—Theophylline—asthma	0.037	0.0527	CbGbCtD
Nilutamide—CYP2C8—Loratadine—asthma	0.0351	0.05	CbGbCtD
Nilutamide—CYP2C8—Montelukast—asthma	0.0351	0.05	CbGbCtD
Nilutamide—CYP2C9—Zafirlukast—asthma	0.0334	0.0476	CbGbCtD
Nilutamide—CYP2C9—Arformoterol—asthma	0.0323	0.046	CbGbCtD
Nilutamide—CYP2C9—Formoterol—asthma	0.0323	0.046	CbGbCtD
Nilutamide—CYP2C19—Loratadine—asthma	0.0294	0.0419	CbGbCtD
Nilutamide—CYP2C9—Theophylline—asthma	0.0258	0.0368	CbGbCtD
Nilutamide—CYP2C9—Loratadine—asthma	0.0245	0.0349	CbGbCtD
Nilutamide—CYP2C9—Montelukast—asthma	0.0245	0.0349	CbGbCtD
Nilutamide—CYP2C8—Hydrocortisone—asthma	0.0195	0.0278	CbGbCtD
Nilutamide—CYP2C19—Prednisone—asthma	0.0163	0.0232	CbGbCtD
Nilutamide—CYP2C8—Dexamethasone—asthma	0.0121	0.0173	CbGbCtD
Nilutamide—CYP2C19—Dexamethasone—asthma	0.0102	0.0145	CbGbCtD
Nilutamide—CYP2C9—Dexamethasone—asthma	0.00846	0.0121	CbGbCtD
Nilutamide—POR—respiratory system—asthma	0.000719	0.126	CbGeAlD
Nilutamide—POR—adrenal cortex—asthma	0.000603	0.106	CbGeAlD
Nilutamide—POR—bronchus—asthma	0.000592	0.104	CbGeAlD
Nilutamide—POR—trachea—asthma	0.000531	0.0931	CbGeAlD
Nilutamide—POR—adrenal gland—asthma	0.000436	0.0763	CbGeAlD
Nilutamide—POR—lung—asthma	0.000382	0.0669	CbGeAlD
Nilutamide—AR—adrenal cortex—asthma	0.000357	0.0625	CbGeAlD
Nilutamide—AR—epithelium—asthma	0.000355	0.0622	CbGeAlD
Nilutamide—AR—bronchus—asthma	0.00035	0.0612	CbGeAlD
Nilutamide—AR—smooth muscle tissue—asthma	0.000342	0.0599	CbGeAlD
Nilutamide—AR—cardiovascular system—asthma	0.000325	0.057	CbGeAlD
Nilutamide—AR—adrenal gland—asthma	0.000257	0.0451	CbGeAlD
Nilutamide—AR—Coregulation of Androgen receptor activity—CARM1—asthma	0.000249	0.0144	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—PARP1—asthma	0.000243	0.0141	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—LTA4H—asthma	0.000239	0.0138	CbGpPWpGaD
Nilutamide—CYP2C9—cardiovascular system—asthma	0.000234	0.0409	CbGeAlD
Nilutamide—AR—lung—asthma	0.000226	0.0395	CbGeAlD
Nilutamide—CYP2C9—Arachidonic acid metabolism—LTA4H—asthma	0.000218	0.0126	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptors—VDR—asthma	0.000217	0.0125	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptor transcription pathway—ESR2—asthma	0.000216	0.0125	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptors—NR3C1—asthma	0.000195	0.0113	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—HNMT—asthma	0.000187	0.0108	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CARM1—asthma	0.000184	0.0106	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptor transcription pathway—VDR—asthma	0.000171	0.0099	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—ALOX15—asthma	0.000168	0.00971	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—ALOX5AP—asthma	0.000168	0.00971	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—HNMT—asthma	0.000167	0.00965	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—RAD50—asthma	0.000167	0.00962	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—GATA3—asthma	0.000166	0.00959	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—IL5—asthma	0.000157	0.00909	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptor transcription pathway—NR3C1—asthma	0.000154	0.00891	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—HNMT—asthma	0.000152	0.0088	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—ALOX5AP—asthma	0.00015	0.00867	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—ALOX15—asthma	0.00015	0.00867	CbGpPWpGaD
Nilutamide—AR—Regulation of Androgen receptor activity—NR3C1—asthma	0.00015	0.00864	CbGpPWpGaD
Nilutamide—Asthenia—Arformoterol—asthma	0.000147	0.000536	CcSEcCtD
Nilutamide—Asthenia—Formoterol—asthma	0.000147	0.000536	CcSEcCtD
Nilutamide—Hyperglycaemia—Dexamethasone—asthma	0.000147	0.000535	CcSEcCtD
Nilutamide—Hyperglycaemia—Betamethasone—asthma	0.000147	0.000535	CcSEcCtD
Nilutamide—Pruritus—Formoterol—asthma	0.000145	0.000528	CcSEcCtD
Nilutamide—Pruritus—Arformoterol—asthma	0.000145	0.000528	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Prednisone—asthma	0.000145	0.000527	CcSEcCtD
Nilutamide—Rhinitis—Triamcinolone—asthma	0.000144	0.000525	CcSEcCtD
Nilutamide—Asthenia—Montelukast—asthma	0.000144	0.000525	CcSEcCtD
Nilutamide—Rhinitis—Methylprednisolone—asthma	0.000144	0.000524	CcSEcCtD
Nilutamide—CYP2C8—Arachidonic acid metabolism—ALOX5—asthma	0.000143	0.00826	CbGpPWpGaD
Nilutamide—Pruritus—Montelukast—asthma	0.000142	0.000518	CcSEcCtD
Nilutamide—Diarrhoea—Formoterol—asthma	0.000141	0.000511	CcSEcCtD
Nilutamide—Diarrhoea—Arformoterol—asthma	0.000141	0.000511	CcSEcCtD
Nilutamide—Nausea—Flunisolide—asthma	0.00014	0.00051	CcSEcCtD
Nilutamide—Asthenia—Salbutamol—asthma	0.000139	0.000506	CcSEcCtD
Nilutamide—Vomiting—Mometasone—asthma	0.000139	0.000506	CcSEcCtD
Nilutamide—Visual impairment—Methylprednisolone—asthma	0.000138	0.000503	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—RAD50—asthma	0.000138	0.00797	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CHAT—asthma	0.000138	0.00797	CbGpPWpGaD
Nilutamide—Rash—Mometasone—asthma	0.000138	0.000502	CcSEcCtD
Nilutamide—Dermatitis—Mometasone—asthma	0.000138	0.000501	CcSEcCtD
Nilutamide—Diarrhoea—Montelukast—asthma	0.000138	0.000501	CcSEcCtD
Nilutamide—Pruritus—Salbutamol—asthma	0.000137	0.000499	CcSEcCtD
Nilutamide—Headache—Mometasone—asthma	0.000137	0.000498	CcSEcCtD
Nilutamide—CYP2C9—Arachidonic acid metabolism—ALOX5AP—asthma	0.000137	0.0079	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—ALOX15—asthma	0.000137	0.0079	CbGpPWpGaD
Nilutamide—Dizziness—Arformoterol—asthma	0.000136	0.000494	CcSEcCtD
Nilutamide—Dizziness—Formoterol—asthma	0.000136	0.000494	CcSEcCtD
Nilutamide—Asthenia—Budesonide—asthma	0.000135	0.00049	CcSEcCtD
Nilutamide—Dizziness—Montelukast—asthma	0.000133	0.000484	CcSEcCtD
Nilutamide—Pruritus—Budesonide—asthma	0.000133	0.000483	CcSEcCtD
Nilutamide—Diarrhoea—Salbutamol—asthma	0.000133	0.000483	CcSEcCtD
Nilutamide—Erectile dysfunction—Prednisone—asthma	0.000131	0.000476	CcSEcCtD
Nilutamide—Vomiting—Formoterol—asthma	0.000131	0.000475	CcSEcCtD
Nilutamide—Vomiting—Arformoterol—asthma	0.000131	0.000475	CcSEcCtD
Nilutamide—Nausea—Mometasone—asthma	0.00013	0.000473	CcSEcCtD
Nilutamide—Rash—Arformoterol—asthma	0.00013	0.000471	CcSEcCtD
Nilutamide—Rash—Formoterol—asthma	0.00013	0.000471	CcSEcCtD
Nilutamide—Dermatitis—Formoterol—asthma	0.000129	0.00047	CcSEcCtD
Nilutamide—Dermatitis—Arformoterol—asthma	0.000129	0.00047	CcSEcCtD
Nilutamide—Headache—Formoterol—asthma	0.000129	0.000468	CcSEcCtD
Nilutamide—Headache—Arformoterol—asthma	0.000129	0.000468	CcSEcCtD
Nilutamide—Weight decreased—Prednisone—asthma	0.000129	0.000468	CcSEcCtD
Nilutamide—Diarrhoea—Budesonide—asthma	0.000129	0.000467	CcSEcCtD
Nilutamide—Dizziness—Salbutamol—asthma	0.000128	0.000466	CcSEcCtD
Nilutamide—Hyperglycaemia—Prednisone—asthma	0.000128	0.000466	CcSEcCtD
Nilutamide—Vomiting—Montelukast—asthma	0.000128	0.000465	CcSEcCtD
Nilutamide—CYP2C19—Arachidonic acid metabolism—ALOX5—asthma	0.000128	0.00737	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—MYB—asthma	0.000127	0.00736	CbGpPWpGaD
Nilutamide—Rash—Montelukast—asthma	0.000127	0.000461	CcSEcCtD
Nilutamide—Dermatitis—Montelukast—asthma	0.000127	0.000461	CcSEcCtD
Nilutamide—Ill-defined disorder—Prednisolone—asthma	0.000126	0.00046	CcSEcCtD
Nilutamide—Depression—Prednisone—asthma	0.000126	0.00046	CcSEcCtD
Nilutamide—Headache—Montelukast—asthma	0.000126	0.000458	CcSEcCtD
Nilutamide—Visual impairment—Betamethasone—asthma	0.000126	0.000458	CcSEcCtD
Nilutamide—Visual impairment—Dexamethasone—asthma	0.000126	0.000458	CcSEcCtD
Nilutamide—Dizziness—Budesonide—asthma	0.000124	0.000452	CcSEcCtD
Nilutamide—Ill-defined disorder—Hydrocortisone—asthma	0.000124	0.000449	CcSEcCtD
Nilutamide—Vomiting—Salbutamol—asthma	0.000123	0.000448	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—IL1R1—asthma	0.000123	0.00711	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—TACR1—asthma	0.000123	0.0071	CbGpPWpGaD
Nilutamide—Malaise—Prednisolone—asthma	0.000123	0.000447	CcSEcCtD
Nilutamide—Rash—Salbutamol—asthma	0.000122	0.000445	CcSEcCtD
Nilutamide—Syncope—Prednisolone—asthma	0.000122	0.000444	CcSEcCtD
Nilutamide—Dermatitis—Salbutamol—asthma	0.000122	0.000444	CcSEcCtD
Nilutamide—Nausea—Arformoterol—asthma	0.000122	0.000444	CcSEcCtD
Nilutamide—Nausea—Formoterol—asthma	0.000122	0.000444	CcSEcCtD
Nilutamide—Headache—Salbutamol—asthma	0.000122	0.000442	CcSEcCtD
Nilutamide—Back pain—Triamcinolone—asthma	0.000121	0.000441	CcSEcCtD
Nilutamide—Malaise—Hydrocortisone—asthma	0.00012	0.000437	CcSEcCtD
Nilutamide—Loss of consciousness—Prednisolone—asthma	0.00012	0.000436	CcSEcCtD
Nilutamide—Nausea—Montelukast—asthma	0.00012	0.000435	CcSEcCtD
Nilutamide—Vomiting—Budesonide—asthma	0.000119	0.000434	CcSEcCtD
Nilutamide—Syncope—Hydrocortisone—asthma	0.000119	0.000434	CcSEcCtD
Nilutamide—Rash—Budesonide—asthma	0.000118	0.000431	CcSEcCtD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—VDR—asthma	0.000118	0.00684	CbGpPWpGaD
Nilutamide—Dermatitis—Budesonide—asthma	0.000118	0.00043	CcSEcCtD
Nilutamide—Headache—Budesonide—asthma	0.000118	0.000428	CcSEcCtD
Nilutamide—Hypertension—Prednisolone—asthma	0.000118	0.000428	CcSEcCtD
Nilutamide—Loss of consciousness—Hydrocortisone—asthma	0.000117	0.000425	CcSEcCtD
Nilutamide—CYP2C9—Arachidonic acid metabolism—ALOX5—asthma	0.000116	0.00672	CbGpPWpGaD
Nilutamide—Ill-defined disorder—Triamcinolone—asthma	0.000116	0.000423	CcSEcCtD
Nilutamide—Ill-defined disorder—Methylprednisolone—asthma	0.000116	0.000422	CcSEcCtD
Nilutamide—Alopecia—Dexamethasone—asthma	0.000115	0.00042	CcSEcCtD
Nilutamide—Alopecia—Betamethasone—asthma	0.000115	0.00042	CcSEcCtD
Nilutamide—Nausea—Salbutamol—asthma	0.000115	0.000419	CcSEcCtD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—IL10—asthma	0.000115	0.00665	CbGpPWpGaD
Nilutamide—Hypertension—Hydrocortisone—asthma	0.000115	0.000418	CcSEcCtD
Nilutamide—Discomfort—Prednisolone—asthma	0.000115	0.000417	CcSEcCtD
Nilutamide—Enzalutamide—ALB—asthma	0.000114	1	CrCbGaD
Nilutamide—Malaise—Triamcinolone—asthma	0.000113	0.000411	CcSEcCtD
Nilutamide—Malaise—Methylprednisolone—asthma	0.000113	0.00041	CcSEcCtD
Nilutamide—Syncope—Triamcinolone—asthma	0.000112	0.000409	CcSEcCtD
Nilutamide—Syncope—Methylprednisolone—asthma	0.000112	0.000408	CcSEcCtD
Nilutamide—Discomfort—Hydrocortisone—asthma	0.000112	0.000407	CcSEcCtD
Nilutamide—Nausea—Budesonide—asthma	0.000112	0.000406	CcSEcCtD
Nilutamide—Oedema—Prednisolone—asthma	0.000111	0.000404	CcSEcCtD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—SMAD3—asthma	0.000111	0.0064	CbGpPWpGaD
Nilutamide—CYP2C19—Melatonin metabolism and effects—EDN1—asthma	0.000111	0.00639	CbGpPWpGaD
Nilutamide—Loss of consciousness—Triamcinolone—asthma	0.00011	0.000401	CcSEcCtD
Nilutamide—Loss of consciousness—Methylprednisolone—asthma	0.00011	0.0004	CcSEcCtD
Nilutamide—Shock—Prednisolone—asthma	0.000109	0.000398	CcSEcCtD
Nilutamide—Cough—Triamcinolone—asthma	0.000109	0.000398	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—IL13—asthma	0.000109	0.00629	CbGpPWpGaD
Nilutamide—Oedema—Hydrocortisone—asthma	0.000109	0.000395	CcSEcCtD
Nilutamide—Hypertension—Triamcinolone—asthma	0.000108	0.000393	CcSEcCtD
Nilutamide—Hypertension—Methylprednisolone—asthma	0.000108	0.000393	CcSEcCtD
Nilutamide—Hyperhidrosis—Prednisolone—asthma	0.000108	0.000391	CcSEcCtD
Nilutamide—Shock—Hydrocortisone—asthma	0.000107	0.000389	CcSEcCtD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—asthma	0.000107	0.00615	CbGpPWpGaD
Nilutamide—Ill-defined disorder—Betamethasone—asthma	0.000106	0.000384	CcSEcCtD
Nilutamide—Ill-defined disorder—Dexamethasone—asthma	0.000106	0.000384	CcSEcCtD
Nilutamide—Discomfort—Triamcinolone—asthma	0.000105	0.000383	CcSEcCtD
Nilutamide—Discomfort—Methylprednisolone—asthma	0.000105	0.000383	CcSEcCtD
Nilutamide—Hyperhidrosis—Hydrocortisone—asthma	0.000105	0.000382	CcSEcCtD
Nilutamide—Dry mouth—Triamcinolone—asthma	0.000104	0.000379	CcSEcCtD
Nilutamide—Anorexia—Hydrocortisone—asthma	0.000104	0.000377	CcSEcCtD
Nilutamide—AR—Androgen receptor signaling pathway—SMAD3—asthma	0.000103	0.00594	CbGpPWpGaD
Nilutamide—Malaise—Betamethasone—asthma	0.000103	0.000373	CcSEcCtD
Nilutamide—Malaise—Dexamethasone—asthma	0.000103	0.000373	CcSEcCtD
Nilutamide—Oedema—Triamcinolone—asthma	0.000102	0.000372	CcSEcCtD
Nilutamide—Syncope—Dexamethasone—asthma	0.000102	0.000371	CcSEcCtD
Nilutamide—Syncope—Betamethasone—asthma	0.000102	0.000371	CcSEcCtD
Nilutamide—AR—Notch-mediated HES/HEY network—CD4—asthma	0.000101	0.00584	CbGpPWpGaD
Nilutamide—Shock—Triamcinolone—asthma	0.000101	0.000366	CcSEcCtD
Nilutamide—Insomnia—Prednisolone—asthma	0.000101	0.000366	CcSEcCtD
Nilutamide—Alopecia—Prednisone—asthma	0.000101	0.000366	CcSEcCtD
Nilutamide—Shock—Methylprednisolone—asthma	0.0001	0.000365	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—TAC1—asthma	0.0001	0.00579	CbGpPWpGaD
Nilutamide—Loss of consciousness—Betamethasone—asthma	0.0001	0.000363	CcSEcCtD
Nilutamide—Loss of consciousness—Dexamethasone—asthma	0.0001	0.000363	CcSEcCtD
Nilutamide—Paraesthesia—Prednisolone—asthma	9.99e-05	0.000363	CcSEcCtD
Nilutamide—Hyperhidrosis—Triamcinolone—asthma	9.89e-05	0.00036	CcSEcCtD
Nilutamide—Hyperhidrosis—Methylprednisolone—asthma	9.87e-05	0.000359	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—GATA3—asthma	9.83e-05	0.00568	CbGpPWpGaD
Nilutamide—Insomnia—Hydrocortisone—asthma	9.83e-05	0.000357	CcSEcCtD
Nilutamide—Hypertension—Betamethasone—asthma	9.82e-05	0.000357	CcSEcCtD
Nilutamide—Hypertension—Dexamethasone—asthma	9.82e-05	0.000357	CcSEcCtD
Nilutamide—Paraesthesia—Hydrocortisone—asthma	9.76e-05	0.000355	CcSEcCtD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDK2—asthma	9.61e-05	0.00555	CbGpPWpGaD
Nilutamide—Discomfort—Dexamethasone—asthma	9.57e-05	0.000348	CcSEcCtD
Nilutamide—Discomfort—Betamethasone—asthma	9.57e-05	0.000348	CcSEcCtD
Nilutamide—Dyspepsia—Hydrocortisone—asthma	9.56e-05	0.000348	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—IL1RN—asthma	9.52e-05	0.0055	CbGpPWpGaD
Nilutamide—Pain—Prednisolone—asthma	9.51e-05	0.000346	CcSEcCtD
Nilutamide—Decreased appetite—Hydrocortisone—asthma	9.44e-05	0.000343	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Hydrocortisone—asthma	9.38e-05	0.000341	CcSEcCtD
Nilutamide—Pain—Hydrocortisone—asthma	9.29e-05	0.000338	CcSEcCtD
Nilutamide—Oedema—Dexamethasone—asthma	9.28e-05	0.000338	CcSEcCtD
Nilutamide—Oedema—Betamethasone—asthma	9.28e-05	0.000338	CcSEcCtD
Nilutamide—Insomnia—Triamcinolone—asthma	9.25e-05	0.000336	CcSEcCtD
Nilutamide—Insomnia—Methylprednisolone—asthma	9.23e-05	0.000336	CcSEcCtD
Nilutamide—Ill-defined disorder—Prednisone—asthma	9.19e-05	0.000334	CcSEcCtD
Nilutamide—Paraesthesia—Triamcinolone—asthma	9.19e-05	0.000334	CcSEcCtD
Nilutamide—Feeling abnormal—Prednisolone—asthma	9.17e-05	0.000333	CcSEcCtD
Nilutamide—Paraesthesia—Methylprednisolone—asthma	9.17e-05	0.000333	CcSEcCtD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—ALDH2—asthma	9.16e-05	0.00529	CbGpPWpGaD
Nilutamide—Anaemia—Prednisone—asthma	9.15e-05	0.000333	CcSEcCtD
Nilutamide—Shock—Dexamethasone—asthma	9.13e-05	0.000332	CcSEcCtD
Nilutamide—Shock—Betamethasone—asthma	9.13e-05	0.000332	CcSEcCtD
Nilutamide—Dyspnoea—Triamcinolone—asthma	9.12e-05	0.000332	CcSEcCtD
Nilutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	9.03e-05	0.00521	CbGpPWpGaD
Nilutamide—Dyspepsia—Triamcinolone—asthma	9.01e-05	0.000327	CcSEcCtD
Nilutamide—Dyspepsia—Methylprednisolone—asthma	8.99e-05	0.000327	CcSEcCtD
Nilutamide—Hyperhidrosis—Dexamethasone—asthma	8.97e-05	0.000326	CcSEcCtD
Nilutamide—Hyperhidrosis—Betamethasone—asthma	8.97e-05	0.000326	CcSEcCtD
Nilutamide—Feeling abnormal—Hydrocortisone—asthma	8.95e-05	0.000326	CcSEcCtD
Nilutamide—Malaise—Prednisone—asthma	8.93e-05	0.000325	CcSEcCtD
Nilutamide—Gastrointestinal pain—Hydrocortisone—asthma	8.88e-05	0.000323	CcSEcCtD
Nilutamide—Syncope—Prednisone—asthma	8.88e-05	0.000323	CcSEcCtD
Nilutamide—Anorexia—Betamethasone—asthma	8.85e-05	0.000322	CcSEcCtD
Nilutamide—Anorexia—Dexamethasone—asthma	8.85e-05	0.000322	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—ESR2—asthma	8.83e-05	0.0051	CbGpPWpGaD
Nilutamide—Pain—Triamcinolone—asthma	8.75e-05	0.000318	CcSEcCtD
Nilutamide—Loss of consciousness—Prednisone—asthma	8.71e-05	0.000317	CcSEcCtD
Nilutamide—Abdominal pain—Hydrocortisone—asthma	8.59e-05	0.000312	CcSEcCtD
Nilutamide—Body temperature increased—Hydrocortisone—asthma	8.59e-05	0.000312	CcSEcCtD
Nilutamide—Hypertension—Prednisone—asthma	8.55e-05	0.000311	CcSEcCtD
Nilutamide—Feeling abnormal—Triamcinolone—asthma	8.43e-05	0.000307	CcSEcCtD
Nilutamide—Feeling abnormal—Methylprednisolone—asthma	8.41e-05	0.000306	CcSEcCtD
Nilutamide—Insomnia—Betamethasone—asthma	8.4e-05	0.000305	CcSEcCtD
Nilutamide—Insomnia—Dexamethasone—asthma	8.4e-05	0.000305	CcSEcCtD
Nilutamide—Gastrointestinal pain—Methylprednisolone—asthma	8.35e-05	0.000303	CcSEcCtD
Nilutamide—Paraesthesia—Dexamethasone—asthma	8.34e-05	0.000303	CcSEcCtD
Nilutamide—Paraesthesia—Betamethasone—asthma	8.34e-05	0.000303	CcSEcCtD
Nilutamide—Discomfort—Prednisone—asthma	8.33e-05	0.000303	CcSEcCtD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—asthma	8.18e-05	0.00472	CbGpPWpGaD
Nilutamide—Dyspepsia—Betamethasone—asthma	8.17e-05	0.000297	CcSEcCtD
Nilutamide—Dyspepsia—Dexamethasone—asthma	8.17e-05	0.000297	CcSEcCtD
Nilutamide—Body temperature increased—Triamcinolone—asthma	8.09e-05	0.000294	CcSEcCtD
Nilutamide—Oedema—Prednisone—asthma	8.08e-05	0.000294	CcSEcCtD
Nilutamide—Abdominal pain—Methylprednisolone—asthma	8.07e-05	0.000293	CcSEcCtD
Nilutamide—Decreased appetite—Betamethasone—asthma	8.07e-05	0.000293	CcSEcCtD
Nilutamide—Decreased appetite—Dexamethasone—asthma	8.07e-05	0.000293	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Dexamethasone—asthma	8.01e-05	0.000291	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Betamethasone—asthma	8.01e-05	0.000291	CcSEcCtD
Nilutamide—Shock—Prednisone—asthma	7.95e-05	0.000289	CcSEcCtD
Nilutamide—Pain—Betamethasone—asthma	7.94e-05	0.000289	CcSEcCtD
Nilutamide—Pain—Dexamethasone—asthma	7.94e-05	0.000289	CcSEcCtD
Nilutamide—CYP2C8—Arachidonic acid metabolism—PLA2G4A—asthma	7.92e-05	0.00458	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—STAT3—asthma	7.83e-05	0.00452	CbGpPWpGaD
Nilutamide—Hyperhidrosis—Prednisone—asthma	7.81e-05	0.000284	CcSEcCtD
Nilutamide—Asthenia—Hydrocortisone—asthma	7.8e-05	0.000283	CcSEcCtD
Nilutamide—Anorexia—Prednisone—asthma	7.71e-05	0.00028	CcSEcCtD
Nilutamide—Pruritus—Hydrocortisone—asthma	7.69e-05	0.000279	CcSEcCtD
Nilutamide—Feeling abnormal—Dexamethasone—asthma	7.65e-05	0.000278	CcSEcCtD
Nilutamide—Feeling abnormal—Betamethasone—asthma	7.65e-05	0.000278	CcSEcCtD
Nilutamide—Gastrointestinal pain—Dexamethasone—asthma	7.59e-05	0.000276	CcSEcCtD
Nilutamide—Gastrointestinal pain—Betamethasone—asthma	7.59e-05	0.000276	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—ESR2—asthma	7.51e-05	0.00434	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—asthma	7.46e-05	0.00431	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—asthma	7.43e-05	0.00429	CbGpPWpGaD
Nilutamide—Diarrhoea—Hydrocortisone—asthma	7.43e-05	0.00027	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—IL3—asthma	7.38e-05	0.00426	CbGpPWpGaD
Nilutamide—Dizziness—Prednisolone—asthma	7.36e-05	0.000267	CcSEcCtD
Nilutamide—Asthenia—Triamcinolone—asthma	7.34e-05	0.000267	CcSEcCtD
Nilutamide—Abdominal pain—Dexamethasone—asthma	7.34e-05	0.000267	CcSEcCtD
Nilutamide—Body temperature increased—Dexamethasone—asthma	7.34e-05	0.000267	CcSEcCtD
Nilutamide—Abdominal pain—Betamethasone—asthma	7.34e-05	0.000267	CcSEcCtD
Nilutamide—Body temperature increased—Betamethasone—asthma	7.34e-05	0.000267	CcSEcCtD
Nilutamide—Asthenia—Methylprednisolone—asthma	7.32e-05	0.000266	CcSEcCtD
Nilutamide—Insomnia—Prednisone—asthma	7.31e-05	0.000266	CcSEcCtD
Nilutamide—Paraesthesia—Prednisone—asthma	7.26e-05	0.000264	CcSEcCtD
Nilutamide—Pruritus—Triamcinolone—asthma	7.24e-05	0.000263	CcSEcCtD
Nilutamide—Pruritus—Methylprednisolone—asthma	7.22e-05	0.000263	CcSEcCtD
Nilutamide—Dizziness—Hydrocortisone—asthma	7.18e-05	0.000261	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—BDNF—asthma	7.14e-05	0.00412	CbGpPWpGaD
Nilutamide—Dyspepsia—Prednisone—asthma	7.12e-05	0.000259	CcSEcCtD
Nilutamide—CYP2C19—Arachidonic acid metabolism—PLA2G4A—asthma	7.07e-05	0.00408	CbGpPWpGaD
Nilutamide—Decreased appetite—Prednisone—asthma	7.03e-05	0.000256	CcSEcCtD
Nilutamide—Rash—Prednisolone—asthma	7.01e-05	0.000255	CcSEcCtD
Nilutamide—Dermatitis—Prednisolone—asthma	7.01e-05	0.000255	CcSEcCtD
Nilutamide—Diarrhoea—Methylprednisolone—asthma	6.98e-05	0.000254	CcSEcCtD
Nilutamide—Headache—Prednisolone—asthma	6.97e-05	0.000253	CcSEcCtD
Nilutamide—Constipation—Prednisone—asthma	6.91e-05	0.000251	CcSEcCtD
Nilutamide—Vomiting—Hydrocortisone—asthma	6.91e-05	0.000251	CcSEcCtD
Nilutamide—Rash—Hydrocortisone—asthma	6.85e-05	0.000249	CcSEcCtD
Nilutamide—Dermatitis—Hydrocortisone—asthma	6.84e-05	0.000249	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—IL10—asthma	6.82e-05	0.00394	CbGpPWpGaD
Nilutamide—Headache—Hydrocortisone—asthma	6.81e-05	0.000247	CcSEcCtD
Nilutamide—Dizziness—Triamcinolone—asthma	6.76e-05	0.000246	CcSEcCtD
Nilutamide—Dizziness—Methylprednisolone—asthma	6.75e-05	0.000245	CcSEcCtD
Nilutamide—Feeling abnormal—Prednisone—asthma	6.66e-05	0.000242	CcSEcCtD
Nilutamide—Asthenia—Betamethasone—asthma	6.66e-05	0.000242	CcSEcCtD
Nilutamide—Asthenia—Dexamethasone—asthma	6.66e-05	0.000242	CcSEcCtD
Nilutamide—AR—Androgen receptor signaling pathway—RHOA—asthma	6.65e-05	0.00384	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	6.63e-05	0.00383	CbGpPWpGaD
Nilutamide—Gastrointestinal pain—Prednisone—asthma	6.61e-05	0.00024	CcSEcCtD
Nilutamide—Nausea—Prednisolone—asthma	6.61e-05	0.00024	CcSEcCtD
Nilutamide—Pruritus—Dexamethasone—asthma	6.57e-05	0.000239	CcSEcCtD
Nilutamide—Pruritus—Betamethasone—asthma	6.57e-05	0.000239	CcSEcCtD
Nilutamide—Vomiting—Triamcinolone—asthma	6.5e-05	0.000237	CcSEcCtD
Nilutamide—Vomiting—Methylprednisolone—asthma	6.49e-05	0.000236	CcSEcCtD
Nilutamide—Nausea—Hydrocortisone—asthma	6.45e-05	0.000235	CcSEcCtD
Nilutamide—Rash—Triamcinolone—asthma	6.45e-05	0.000235	CcSEcCtD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PLA2G4A—asthma	6.45e-05	0.00372	CbGpPWpGaD
Nilutamide—Dermatitis—Triamcinolone—asthma	6.44e-05	0.000234	CcSEcCtD
Nilutamide—Rash—Methylprednisolone—asthma	6.44e-05	0.000234	CcSEcCtD
Nilutamide—Dermatitis—Methylprednisolone—asthma	6.43e-05	0.000234	CcSEcCtD
Nilutamide—Headache—Triamcinolone—asthma	6.41e-05	0.000233	CcSEcCtD
Nilutamide—Headache—Methylprednisolone—asthma	6.39e-05	0.000233	CcSEcCtD
Nilutamide—Body temperature increased—Prednisone—asthma	6.39e-05	0.000232	CcSEcCtD
Nilutamide—Abdominal pain—Prednisone—asthma	6.39e-05	0.000232	CcSEcCtD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—asthma	6.36e-05	0.00367	CbGpPWpGaD
Nilutamide—Diarrhoea—Dexamethasone—asthma	6.35e-05	0.000231	CcSEcCtD
Nilutamide—Diarrhoea—Betamethasone—asthma	6.35e-05	0.000231	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—NR3C1—asthma	6.31e-05	0.00364	CbGpPWpGaD
Nilutamide—Dizziness—Betamethasone—asthma	6.14e-05	0.000223	CcSEcCtD
Nilutamide—Dizziness—Dexamethasone—asthma	6.14e-05	0.000223	CcSEcCtD
Nilutamide—Nausea—Triamcinolone—asthma	6.08e-05	0.000221	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BDNF—asthma	6.07e-05	0.00351	CbGpPWpGaD
Nilutamide—Nausea—Methylprednisolone—asthma	6.06e-05	0.00022	CcSEcCtD
Nilutamide—Vomiting—Betamethasone—asthma	5.9e-05	0.000215	CcSEcCtD
Nilutamide—Vomiting—Dexamethasone—asthma	5.9e-05	0.000215	CcSEcCtD
Nilutamide—Rash—Betamethasone—asthma	5.85e-05	0.000213	CcSEcCtD
Nilutamide—Rash—Dexamethasone—asthma	5.85e-05	0.000213	CcSEcCtD
Nilutamide—Dermatitis—Betamethasone—asthma	5.85e-05	0.000213	CcSEcCtD
Nilutamide—Dermatitis—Dexamethasone—asthma	5.85e-05	0.000213	CcSEcCtD
Nilutamide—AR—Integrated Breast Cancer Pathway—CDK2—asthma	5.84e-05	0.00337	CbGpPWpGaD
Nilutamide—Headache—Dexamethasone—asthma	5.82e-05	0.000211	CcSEcCtD
Nilutamide—Headache—Betamethasone—asthma	5.82e-05	0.000211	CcSEcCtD
Nilutamide—Asthenia—Prednisone—asthma	5.8e-05	0.000211	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	5.8e-05	0.00335	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—asthma	5.75e-05	0.00332	CbGpPWpGaD
Nilutamide—Pruritus—Prednisone—asthma	5.72e-05	0.000208	CcSEcCtD
Nilutamide—Diarrhoea—Prednisone—asthma	5.53e-05	0.000201	CcSEcCtD
Nilutamide—Nausea—Betamethasone—asthma	5.51e-05	0.0002	CcSEcCtD
Nilutamide—Nausea—Dexamethasone—asthma	5.51e-05	0.0002	CcSEcCtD
Nilutamide—Dizziness—Prednisone—asthma	5.35e-05	0.000194	CcSEcCtD
Nilutamide—AR—Androgen receptor signaling pathway—PTEN—asthma	5.25e-05	0.00303	CbGpPWpGaD
Nilutamide—Vomiting—Prednisone—asthma	5.14e-05	0.000187	CcSEcCtD
Nilutamide—Rash—Prednisone—asthma	5.1e-05	0.000185	CcSEcCtD
Nilutamide—Dermatitis—Prednisone—asthma	5.09e-05	0.000185	CcSEcCtD
Nilutamide—Headache—Prednisone—asthma	5.06e-05	0.000184	CcSEcCtD
Nilutamide—AR—Generic Transcription Pathway—CARM1—asthma	4.96e-05	0.00286	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PRMT5—asthma	4.89e-05	0.00282	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—ALDH2—asthma	4.87e-05	0.00281	CbGpPWpGaD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—asthma	4.84e-05	0.0028	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDK2—asthma	4.84e-05	0.00279	CbGpPWpGaD
Nilutamide—Nausea—Prednisone—asthma	4.8e-05	0.000175	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—IL6R—asthma	4.7e-05	0.00271	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—STAT3—asthma	4.7e-05	0.00271	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GSTT1—asthma	4.63e-05	0.00267	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—asthma	4.47e-05	0.00258	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LTC4S—asthma	4.41e-05	0.00255	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—ALDH2—asthma	4.34e-05	0.00251	CbGpPWpGaD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—asthma	4.32e-05	0.0025	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—EGFR—asthma	4.27e-05	0.00246	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—BCL2—asthma	4.15e-05	0.0024	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GSTT1—asthma	4.13e-05	0.00239	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—asthma	3.99e-05	0.0023	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—ALDH2—asthma	3.96e-05	0.00229	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LTC4S—asthma	3.94e-05	0.00228	CbGpPWpGaD
Nilutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—asthma	3.94e-05	0.00228	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—PARP1—asthma	3.94e-05	0.00227	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—POMC—asthma	3.92e-05	0.00227	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LTA4H—asthma	3.83e-05	0.00221	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTT1—asthma	3.77e-05	0.00218	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—ESR2—asthma	3.73e-05	0.00215	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CXCL8—asthma	3.73e-05	0.00215	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—asthma	3.64e-05	0.0021	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LTC4S—asthma	3.59e-05	0.00207	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL1B—asthma	3.57e-05	0.00206	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—asthma	3.5e-05	0.00202	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BCL2—asthma	3.44e-05	0.00199	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—PTEN—asthma	3.44e-05	0.00199	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LTA4H—asthma	3.42e-05	0.00197	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	3.27e-05	0.00189	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GSTP1—asthma	3.21e-05	0.00185	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—asthma	3.19e-05	0.00184	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—GSTP1—asthma	3.17e-05	0.00183	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—asthma	3.12e-05	0.0018	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—VEGFA—asthma	3.11e-05	0.00179	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—VEGFA—asthma	3.03e-05	0.00175	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—VDR—asthma	2.96e-05	0.00171	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GSTM1—asthma	2.95e-05	0.0017	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—GSTM1—asthma	2.91e-05	0.00168	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GSTP1—asthma	2.86e-05	0.00165	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—asthma	2.85e-05	0.00165	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—GSTP1—asthma	2.83e-05	0.00163	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—EGFR—asthma	2.8e-05	0.00161	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—SMAD3—asthma	2.77e-05	0.0016	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NR3C1—asthma	2.66e-05	0.00154	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GSTM1—asthma	2.63e-05	0.00152	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTP1—asthma	2.61e-05	0.00151	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—GSTM1—asthma	2.6e-05	0.0015	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—TNF—asthma	2.59e-05	0.0015	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—GSTP1—asthma	2.58e-05	0.00149	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	2.57e-05	0.00149	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—asthma	2.4e-05	0.00139	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	2.4e-05	0.00139	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTM1—asthma	2.4e-05	0.00139	CbGpPWpGaD
Nilutamide—AR—Gene Expression—CARM1—asthma	2.39e-05	0.00138	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—GSTM1—asthma	2.37e-05	0.00137	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	2.36e-05	0.00136	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—asthma	2.32e-05	0.00134	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—asthma	2.29e-05	0.00132	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—asthma	2.21e-05	0.00127	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	2.15e-05	0.00124	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—asthma	2.15e-05	0.00124	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL6—asthma	2.09e-05	0.00121	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—POMC—asthma	2.08e-05	0.0012	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—asthma	2.05e-05	0.00118	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—asthma	2.04e-05	0.00118	CbGpPWpGaD
Nilutamide—AR—Gene Expression—DNMT1—asthma	2e-05	0.00116	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LTC4S—asthma	1.97e-05	0.00114	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—asthma	1.96e-05	0.00113	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	1.96e-05	0.00113	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—asthma	1.95e-05	0.00113	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PARP1—asthma	1.9e-05	0.0011	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—asthma	1.87e-05	0.00108	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—POMC—asthma	1.86e-05	0.00107	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—SERPINE1—asthma	1.86e-05	0.00107	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.82e-05	0.00105	CbGpPWpGaD
Nilutamide—AR—Gene Expression—ESR2—asthma	1.8e-05	0.00104	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LTC4S—asthma	1.75e-05	0.00101	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—asthma	1.74e-05	0.00101	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LTA4H—asthma	1.7e-05	0.000984	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—POMC—asthma	1.7e-05	0.00098	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.66e-05	0.000961	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LTC4S—asthma	1.6e-05	0.000924	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—asthma	1.59e-05	0.000916	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LTA4H—asthma	1.52e-05	0.000879	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ARG1—asthma	1.49e-05	0.00086	CbGpPWpGaD
Nilutamide—AR—Gene Expression—VDR—asthma	1.43e-05	0.000823	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LTA4H—asthma	1.39e-05	0.000801	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALDH7A1—asthma	1.35e-05	0.000778	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SMAD3—asthma	1.33e-05	0.000771	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ARG1—asthma	1.33e-05	0.000768	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ARG2—asthma	1.29e-05	0.000746	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NR3C1—asthma	1.28e-05	0.000741	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPP2CA—asthma	1.28e-05	0.000737	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ARG1—asthma	1.21e-05	0.0007	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALDH7A1—asthma	1.2e-05	0.000695	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ARG2—asthma	1.15e-05	0.000666	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.13e-05	0.000654	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALDH7A1—asthma	1.1e-05	0.000633	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALOX5AP—asthma	1.07e-05	0.000618	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALOX15—asthma	1.07e-05	0.000618	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ARG2—asthma	1.05e-05	0.000607	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CHAT—asthma	1.02e-05	0.00059	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.01e-05	0.000584	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALOX15—asthma	9.55e-06	0.000552	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALOX5AP—asthma	9.55e-06	0.000552	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	9.22e-06	0.000532	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CHAT—asthma	9.11e-06	0.000526	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALOX5—asthma	9.1e-06	0.000526	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SERPINE1—asthma	8.95e-06	0.000517	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALOX15—asthma	8.71e-06	0.000503	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALOX5AP—asthma	8.71e-06	0.000503	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CARM1—asthma	8.68e-06	0.000501	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—DCN—asthma	8.56e-06	0.000494	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALDH2—asthma	8.32e-06	0.000481	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CHAT—asthma	8.31e-06	0.00048	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALOX5—asthma	8.12e-06	0.000469	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—asthma	8e-06	0.000462	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTT1—asthma	7.92e-06	0.000457	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CARM1—asthma	7.75e-06	0.000448	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—DCN—asthma	7.64e-06	0.000441	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALDH2—asthma	7.43e-06	0.000429	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALOX5—asthma	7.41e-06	0.000428	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—asthma	7.3e-06	0.000421	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—asthma	7.14e-06	0.000413	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTT1—asthma	7.07e-06	0.000408	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CARM1—asthma	7.07e-06	0.000408	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—DCN—asthma	6.96e-06	0.000402	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALDH2—asthma	6.77e-06	0.000391	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NQO1—asthma	6.58e-06	0.00038	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	6.51e-06	0.000376	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—asthma	6.51e-06	0.000376	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTT1—asthma	6.44e-06	0.000372	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADCY2—asthma	6.44e-06	0.000372	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—asthma	6.38e-06	0.000369	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	5.94e-06	0.000343	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NQO1—asthma	5.87e-06	0.000339	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADCY2—asthma	5.75e-06	0.000332	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	5.7e-06	0.000329	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	5.57e-06	0.000322	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTP1—asthma	5.49e-06	0.000317	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMOX1—asthma	5.41e-06	0.000313	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ITPR1—asthma	5.4e-06	0.000312	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NQO1—asthma	5.36e-06	0.000309	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CAT—asthma	5.34e-06	0.000308	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADCY2—asthma	5.24e-06	0.000303	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	5.2e-06	0.0003	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTM1—asthma	5.04e-06	0.000291	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLA2G4A—asthma	5.04e-06	0.000291	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	4.97e-06	0.000287	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTP1—asthma	4.9e-06	0.000283	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMOX1—asthma	4.83e-06	0.000279	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ITPR1—asthma	4.82e-06	0.000278	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CAT—asthma	4.77e-06	0.000275	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPP2CA—asthma	4.64e-06	0.000268	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	4.53e-06	0.000262	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLA2G4A—asthma	4.5e-06	0.00026	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTM1—asthma	4.5e-06	0.00026	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTP1—asthma	4.47e-06	0.000258	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMOX1—asthma	4.41e-06	0.000254	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ITPR1—asthma	4.4e-06	0.000254	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CAT—asthma	4.35e-06	0.000251	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPP2CA—asthma	4.15e-06	0.000239	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLA2G4A—asthma	4.1e-06	0.000237	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTM1—asthma	4.1e-06	0.000237	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPP2CA—asthma	3.78e-06	0.000218	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—POMC—asthma	3.56e-06	0.000206	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALB—asthma	3.25e-06	0.000188	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—POMC—asthma	3.18e-06	0.000184	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NOS3—asthma	3.11e-06	0.00018	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—POMC—asthma	2.9e-06	0.000168	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALB—asthma	2.9e-06	0.000168	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—asthma	2.84e-06	0.000164	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NOS3—asthma	2.77e-06	0.00016	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALB—asthma	2.64e-06	0.000153	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—asthma	2.54e-06	0.000147	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NOS3—asthma	2.53e-06	0.000146	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTEN—asthma	2.48e-06	0.000143	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—asthma	2.31e-06	0.000134	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTEN—asthma	2.21e-06	0.000128	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTEN—asthma	2.02e-06	0.000117	CbGpPWpGaD
